Clinical significance of p95HER2 Overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Author
Serdengecti, S.
Demirelli, F.
Ozguroglu, M.
Turna, H.
Tural, D.
Buyukunal, E.
Ozturk, T.
Ilvan, S.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/151899
Collections